Leonardo DRS (DRS) traded lower on April 16, 2026, with the decline consistent with a valuation-driven pullback rather than a single fresh company-specific headline. The stock has been pricing in robust demand and backlog strength, but investors are re-centering on profitability execution—particularly the company’s expectation that early-2026 adjusted EBITDA margin sits in the low-11% area, a level that can look tight for a stock that has rerated higher over the past year.

The margin debate has been active since the company’s most recent updates highlighted strong bookings/backlog and maintained full-year expectations, while also acknowledging pressure points such as mix, program timing, and investment spend. With the market increasingly sensitive to earnings quality, any signal that near-term margins could lag the longer-term expansion story tends to spark quick profit-taking, especially after strong performance into 2026.

Key near-term catalysts are the next earnings update for confirmation that (a) backlog is converting on schedule, (b) supply chain constraints remain manageable, and (c) margins inflect as the year progresses rather than staying pinned near the low-11% range. Investors will also watch for incremental contract wins or program milestones that can change mix toward higher-margin work, as well as any change to full-year revenue, EBITDA, or free-cash-flow conversion targets.